Evogene Ltd.
NASDAQ:EVGN
2.74 (USD) • At close September 18, 2024
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | |||||||||||||
| Nettowinst
| -23.879 | -29.844 | -30.445 | -26.206 | -19.115 | -20.812 | -20.838 | -19.592 | -17.213 | -14.53 | -8.878 | -2.522 | 0.645 |
| Afschrijvingen & Amortisatie
| 2.612 | 2.58 | 2.234 | 2.727 | 2.769 | 2.02 | 2.145 | 2.279 | 2.433 | 2.249 | 2.042 | 1.835 | 1.419 |
| Uitgestelde Inkomstenbelasting
| -0.033 | 0.09 | 0.013 | 0.013 | 0.024 | 0.03 | 0.011 | 0.036 | 2.689 | 2.01 | 1.041 | 0.074 | 1.076 |
| Aandelen Gebaseerde Vergoedingen
| 1.877 | 1.186 | 2.609 | 4.097 | 1.578 | 1.731 | 2.244 | 2.943 | 4.365 | 3.23 | 2.73 | 1.173 | 2.129 |
| Verandering in Werkkapitaal
| -0.4 | -0.771 | 1.656 | -1.43 | -0.997 | -0.161 | -0.196 | 1.936 | -3.836 | -0.928 | -2.362 | -2.532 | 0.692 |
| Vorderingen
| -1.454 | -0.067 | -0.059 | -0.15 | 0.088 | -0.028 | 0.037 | 2.506 | -1.492 | 0.73 | -0.345 | -0.742 | 1.341 |
| Voorraden
| 0.49 | -0.474 | -0.092 | -0.912 | -0.895 | 0.146 | 0.351 | -0.279 | -1.218 | -0.83 | 0.874 | 1.31 | -0.165 |
| Crediteuren
| 0.742 | -0.469 | 0.625 | -0.029 | -0.122 | -0.114 | -0.086 | -0.215 | -0.068 | -0.267 | 0.292 | 0.231 | 0.423 |
| Overig Werkkapitaal
| -0.178 | 0.239 | 1.182 | -0.339 | -0.068 | -0.165 | -0.498 | -0.076 | -1.058 | -0.561 | -3.183 | -3.331 | -0.907 |
| Overige Niet-Contante Posten
| -1.754 | 3.081 | -0.906 | 1.285 | -1.623 | 2.031 | 0.705 | 0.705 | -0.845 | -0.926 | 0.157 | 0.084 | -3.828 |
| Kasstroom uit Operationele Activiteiten
| -21.577 | -23.678 | -24.839 | -19.514 | -17.364 | -15.161 | -15.929 | -11.693 | -12.407 | -8.895 | -5.27 | -1.888 | 2.133 |
| Investeringsactiviteiten: | |||||||||||||
| Investeringen in Materiële Vaste Activa
| -0.785 | -1.171 | -0.724 | -0.682 | -0.9 | -0.374 | -0.59 | -0.808 | -2.005 | -3.564 | -1.613 | -2.963 | -3.759 |
| Netto Overnames
| 0.026 | 0 | 0 | 0 | 10 | 0 | -4.757 | -5.461 | 0 | 0 | 0 | -17.618 | 0 |
| Aankoop van Beleggingen
| -10.703 | -0.911 | -24.114 | 0 | -1.637 | -45.912 | -11.659 | -24.561 | -31.168 | -110.661 | -19.444 | -11.935 | -37.542 |
| Verkoop/verval van Beleggingen
| 6.924 | 15.356 | 4.395 | 10.097 | 39.676 | 63.639 | 27.494 | 29.392 | 49.607 | 31.195 | 18.157 | 33.349 | 10.71 |
| Overige Investeringsactiviteiten
| 0 | 0 | 0 | 0 | -10 | 0 | 4.757 | 5.466 | 0.953 | -1 | 0 | 17.652 | 0.009 |
| Kasstroom uit Investeringsactiviteiten
| -4.538 | 13.274 | -20.443 | 9.415 | 37.139 | 17.353 | 15.245 | 4.028 | 17.387 | -84.03 | -2.9 | 18.485 | -30.582 |
| Financieringsactiviteiten: | |||||||||||||
| Schuldaflossingen
| -0.836 | -0.803 | -0.58 | -0.639 | -0.899 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgifte van Gewone Aandelen
| 8.449 | 0.021 | 29.582 | 18.658 | 10 | 0.009 | 0.683 | 0.186 | 0.296 | 0 | 77.014 | 0 | 9.582 |
| Terugkoop van Gewone Aandelen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgekeerde Dividenden
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overige Financieringsactiviteiten
| 10.539 | 10.125 | 1.274 | 2.355 | -0.097 | 0.297 | 0.814 | 0.655 | 0.045 | 2.666 | 2.394 | 1.111 | 15.994 |
| Kasstroom uit Financieringsactiviteiten
| 18.152 | 9.343 | 30.276 | 20.374 | 9.004 | 0.297 | 0.814 | 0.655 | 0.045 | 2.666 | 79.408 | 1.111 | 25.576 |
| Overige Informatie: | |||||||||||||
| Effect van Wisselkoersveranderingen op Kas
| -0.245 | -2.284 | 1.102 | 1.206 | 0.159 | -0.114 | 0.069 | 0.025 | -0.017 | 0.018 | -0.046 | 0.089 | -0.782 |
| Netto Kasstroomverandering
| -8.24 | -3.345 | -13.904 | 11.481 | 28.938 | 2.375 | 0.199 | -6.985 | 5.008 | -90.241 | 71.192 | 17.797 | -3.655 |
| Kaspositie aan het Einde van de Periode
| 20.772 | 28.98 | 32.325 | 46.229 | 34.748 | 5.81 | 3.435 | 3.236 | 10.221 | 5.213 | 95.454 | 24.262 | 6.465 |